Alprazolam Krka 1 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

alprazolam krka 1 mg tablets

krka, d.d., novo mesto - alprazolam - tablet - 1 milligram(s) - benzodiazepine derivatives; alprazolam

Alprazolam Krka 250 microgram tablets Ireland - English - HPRA (Health Products Regulatory Authority)

alprazolam krka 250 microgram tablets

krka, d.d., novo mesto - alprazolam - tablet - 250 microgram(s) - benzodiazepine derivatives; alprazolam

Alprazolam Krka 500 microgram tablets Ireland - English - HPRA (Health Products Regulatory Authority)

alprazolam krka 500 microgram tablets

krka, d.d., novo mesto - alprazolam - tablet - 500 microgram(s) - benzodiazepine derivatives; alprazolam

Alprazolam Krka 0,25 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alprazolam krka 0,25 mg tabl.

krka d.d. novo mesto d.d. - alprazolam 0,25 mg - tablet - 0,25 mg - alprazolam 0.25 mg - alprazolam

Alprazolam Krka 0,5 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alprazolam krka 0,5 mg tabl.

krka d.d. novo mesto d.d. - alprazolam 0,5 mg - tablet - 0,5 mg - alprazolam 0.5 mg - alprazolam

Alprazolam Krka 1 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alprazolam krka 1 mg tabl.

krka d.d. novo mesto d.d. - alprazolam 1 mg - tablet - 1 mg - alprazolam 1 mg - alprazolam

Alprazolam Krka 2 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alprazolam krka 2 mg tabl.

krka d.d. novo mesto d.d. - alprazolam 2 mg - tablet - 2 mg - alprazolam 2 mg - alprazolam

ALPRAZOLAM tablet, orally disintegrating United States - English - NLM (National Library of Medicine)

alprazolam tablet, orally disintegrating

par pharmaceutical, inc. - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam 0.25 mg - alprazolam orally disintegrating tablets, usp are indicated for the treatment of generalized anxiety disorder. the efficacy of alprazolam in the treatment of generalized anxiety disorder was demonstrated in 5 short-term, placebo-controlled trials [see clinical studies (14.1)] . alprazolam orally disintegrating tablets, usp are also indicated for the treatment of panic disorder, with or without agoraphobia. the efficacy of alprazolam in the treatment of panic disorder was established in 2 short-term, placebo-controlled trials [see clinical studies (14.2)] . demonstrations of the effectiveness of alprazolam by systematic clinical study are limited to 4 months in duration for generalized anxiety disorder and 4 to 10 weeks duration for panic disorder; however, patients with panic disorder have been treated on an open basis for up to 8 months without apparent loss of benefit. the physician should periodically reassess the usefulness of the drug for the individual patient. alprazolam orally disintegrating tablets a

ALPRAZOLAM- alprazolam tablet United States - English - NLM (National Library of Medicine)

alprazolam- alprazolam tablet

remedyrepack inc. - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam 1 mg - alprazolam tablets are indicated for the management of anxiety disorder (a condition corresponding most closely to the apa diagnostic and statistical manual [dsm-iii-r] diagnosis of generalized anxiety disorder) or the short-term relief of symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry (apprehensive expectation) about two or more life circumstances, for a period of 6 months or longer, during which the person has been bothered more days than not by these concerns. at least 6 of the following 18 symptoms are often present in these patients: motor tension (trembling, twitching, or feeling shaky; muscle tension, aches, or soreness; restlessness; easy fatigability); autonomic hyperactivity (shortness of breath or smothering sensations; palpitations or accelerated heart rate; sweating, or cold clammy hands; dry mouth; dizziness or l

ALPRAZOLAM- alprazolam tablet United States - English - NLM (National Library of Medicine)

alprazolam- alprazolam tablet

mylan institutional inc. - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam 0.25 mg - alprazolam tablets are indicated for the management of anxiety disorder (a condition corresponding most closely to the apa diagnostic and statistical manual [dsm-iii-r] diagnosis of generalized anxiety disorder) or the short-term relief of symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry (apprehensive expectation) about two or more life circumstances, for a period of 6 months or longer, during which the person has been bothered more days than not by these concerns. at least 6 of the following 18 symptoms are often present in these patients: motor tension (trembling, twitching, or feeling shaky; muscle tension, aches, or soreness; restlessness; easy fatigability); autonomic hyperactivity (shortness of breath or smothering sensations; palpitations or accelerated heart rate; sweating, or cold clammy hands; dry mouth; dizziness or l